Inactive Instrument

Press Releases BioSig Technologies Inc Other OTC

Equities

US09073N1028

Press Releases

Unlock all the news: Be the first to know and act before the market!

BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer	10/06	AQ
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	30/05	AQ
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders	21/05	AQ
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent	03/05	AQ
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately	30/04	AQ
BioSig Technologies : Annual report pursuant to Section 13 and 15(d)	17/04	PU
BioSig Engages Consulting Firm for Business Model Strategies	04/04	AQ
BioSig Technologies : Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT	02/04	PU
BioSig Technologies : Failure to Satisfy Listing Rule - Form 8-K	18/03	PU
BioSig Announces Reduction of its Workforce	20/02	AQ
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases	06/02	AQ
BioSig Announces Reverse Stock Split	31/01	GL
BioSig Announces Reverse Stock Split	31/01	AQ
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy	30/01	GL
BioSig Technologies : Corporate Summary	19/12	PU
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024	07/12	GL
BioSig Issues Letter to Shareholders Detailing Technology Innovations and Strategic Focus for 2024	07/12	AQ
BioSig Technologies : Corporate Summary	28/11	PU
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	14/11	GL
BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	09/11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioSig Technologies Inc Other OTC

Equities

US09073N1028

Press Releases

Filters